Get Premium to unlock powerful stock data
NAS:GNPX (USA)  
Genprex Inc logo

Genprex Inc

$ 1.43 0 (0%) 08:09 PM EST
P/E:
At Loss
P/B:
1.86
Market Cap:
$ 68.50M
Enterprise V:
$ 33.94M
Volume:
67.49K
Avg Vol (2M):
119.22K
Also Trade In:
Volume:
67.49K
Market Cap $:
68.50M
PE Ratio:
At Loss
Avg Vol (2-Month):
119.22K
Enterprise Value $:
33.94M
PB Ratio:
1.86
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Genprex Inc
NAICS : 325412 SIC : 2834
3300 Bee Cave Road, Suite 650-227, Austin, TX, USA, 78746
Description
Genprex Inc is a clinical-stage gene therapy company. It is focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who have limited treatment options. It works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies to provide novel treatment approaches for patients with cancer and diabetes.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.94
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 61.96
9-Day RSI 54.71
14-Day RSI 50.37
6-1 Month Momentum % -33.94
12-1 Month Momentum % -54.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.97
Quick Ratio 14.97
Cash Ratio 14.49

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -46.5
Name Current Vs Industry Vs History
ROE % -42.49
ROA % -41.22
ROIC % -456.38
ROC (Joel Greenblatt) % -1156.76
ROCE % -42.5

Financials (Next Earnings Date:2022-08-12 Est.)

GNPX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:GNPX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.39
Beta -1.03
Volatility % 78.63
14-Day RSI 50.37
14-Day ATR ($) 0.109929
20-Day SMA ($) 1.389
12-1 Month Momentum % -54.8
52-Week Range ($) 1.17 - 3.62
Shares Outstanding (Mil) 47.9

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genprex Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More